A phase III study of Angiomax (bivalirudin) in patients with HIT/HITTS type II undergoing cardiac surgery on cardiopulmonary bypass (CPB).
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2011
At a glance
- Drugs Bivalirudin (Primary)
- Indications Thrombosis
- Focus Therapeutic Use
- 08 Nov 2011 Actual end date (Oct 2005) added as reported by ClinicalTrials.gov.
- 08 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 Oct 2005 New trial record.